US federal appeals court hears arguments in Myriad gene patent case
This article was originally published in SRA
Executive Summary
In a case involving the patentability of isolated DNA, lawyers arguing before the US Court of Appeals for the Federal Circuit on 4 April used hypothetical situations and analogies, for the most part, instead of relying on historical case law on which to base their arguments, with both sides referencing extractions involving everything from baseball bats from trees, to kidneys from the body, to minerals from rocks to get their points across1.